Clinical Trial Update: Study of the Duration and Efficacy of MYDAYIS on Adult ADHD Symptoms and Executive Function Throughout the Day Into the Early Evening [Phase 3]

View source ↗

Summary

Phase 3 study assessing the duration and efficacy of MYDAYIS on adult ADHD symptoms and executive function across the day and into early evening; study complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• MYDAYIS (mixed amphetamine salts, extended-release)

Snippet

Sponsor: NYU Langone Health | Conditions: Attention Deficit-Hyperactivity | Phase 3 | Status: COMPLETED | Results posted: 2023-06-29